Medicine & Health

Todd A. Fehniger, MD, PhD, and co-principal investigators Jeffrey J. Bednarski, MD, PhD, and Thomas Pfeiffer, MD, all at the School of Medicine, have received a total of $1.4 million from the Leukemia & Lymphoma Society, the Rising Tide Foundation for Clinical Cancer Research and Siteman Kids to support a clinical trial of a novel cell-based immunotherapy.

Research led by Rajendra S. Apte, MD, PhD, at the School of Medicine, is the focus of a $15 million pledge from philanthropist Jeffrey T. Fort to accelerate research and develop new treatments for diseases that cause vision loss.

New research from the School of Medicine and the Veterans Affairs St. Louis Health Care System comparing the viruses that cause the flu and COVID-19 shows that people hospitalized with seasonal influenza also can suffer long-term negative health effects.

Hrishikesh S. Kulkarni, MD, an assistant professor of medicine in the Division of Pulmonary & Critical Care Medicine at the School of Medicine, has received the 2023 Svar Complement Excellence Award from the International Complement Society and life sciences company Svar.

New research from the School of Medicine has identified key naturally occurring biochemical components of a novel therapeutic food that is aimed at repairing malnourished children’s underdeveloped gut microbiomes. The findings may help guide treatments for malnutrition.

Smoking shrinks the brain and effectively causes premature brain aging, according to a study by researchers at the School of Medicine. The findings help explain why smokers are at high risk of age-related cognitive decline and Alzheimer’s disease.

David T. Curiel, MD, PhD, and James W. Janetka, PhD, professors at the School of Medicine, have been elected fellows of the National Academy of Inventors.

Matthew A. Ciorba, MD, a professor of medicine and director of the Inflammatory Bowel Disease Center at the School of Medicine, has received a $2.8 million award from the National Institutes of Health (NIH) to evaluate a new treatment for colorectal cancer.

A woman who never developed Alzheimer’s despite a strong genetic predisposition may hold the key to stopping the disease in its tracks. Researchers at the School of Medicine found clues that could help cut the link between the early, asymptomatic stage and the late stage, when cognitive decline sets in.

Washington University in St. Louis researchers will adapt their COVID-19-detecting breathalyzer to one that can also screen for common seasonal viruses with a two-year $3.6 million grant from Flu Lab. With the funding, they plan to take the technology from bench into clinical trials with the goal of preparing the handheld rapid screening breath test for commercial application and FDA registration.